GLP1R and GIPR are key receptors in several diseases, such as diabetes type 2 or obesity. To expand the toolbox of probes available for studying such disorders, at Celtarys we provide fluorescent GLP1R/GIPR dual agonists.
These ligands, developed by Johannes Broichhagen (Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany) and David J. Hodson (Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM)) are exclusively licensed to Celtarys and have been published in peer-reviewed journals.
Celtarys offers the fluorescent dual GLP1R/GIPR probes daLuxendin544+ and daLuxendin660+. They provide a thorough understanding of dual agonist behavior in live mice, which facilitates the study of both hormonal axes and their localization throughout the organism.
Enhance your assays by checking out our selective GLP1 antagonists
-
daLUXendin544+ GLP1R/GIPR fluorescent agonist (561/569) (CELT-118)
For research use only3 nmol vial that allows to prepare 30 µL of 100 µM stock solution to test GLP1R/GIPR. One vial is sufficient for injecting one mouse.
Please note that the required concentration may vary depending on the specific assay design.
525,00€ View more -
daLUXendin660+ GLP1R/GIPR fluorescent agonist (633/662) (CELT-119)
For research use only3 nmol vial that allows to prepare 30 µL of 100 µM stock solution to test GLP1R/GIPR. One vial is sufficient for injecting one mouse.
Please note that the required concentration may vary depending on the specific assay design.
525,00€ View more
Do you want more information?
We are ready to support your challenges